ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CDXI Cardax Inc (CE)

0.000001
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cardax Inc (CE) USOTC:CDXI OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

Current Report Filing (8-k)

13/11/2017 1:01pm

Edgar (US Regulatory)


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 8, 2017

 

CARDAX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   333-181719   45-4484428
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

2800 Woodlawn Drive, Suite 129, Honolulu, Hawaii 96822
(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code: (808) 457-1400
 
 
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

 

 

 

     
 

 

ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

 

On November 8, 2017, the stockholders (the “ Stockholders ”) holding a majority of the outstanding shares of Cardax, Inc., a Delaware corporation (the “ Company ”) as of such date, executed a written consent in lieu of an annual meeting (the “ Written Consent ”). Pursuant to the Written Consent, the Stockholders:

 

  elected the following four directors: George W. Bickerstaff, III, Terence A. Kelly, Michele Galen, and David G. Watumull, as all of the members of the Board of Directors of the Company, and
     
  ratified the appointment of KBL, LLP as the Company’s independent public accountant for the fiscal year ended December 31, 2017.

 

Such election of the directors and the ratification of the appointment of the accountant were authorized by the holders of 67,346,866 votes or 55% of the outstanding voting power.

 

The Written Consent was adopted in accordance with the terms of the applicable law and the charter documents of the Company.

 

    2  

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 13, 2017

 

  CARDAX, INC.
     
  By: /s/ David G. Watumull
    David G. Watumull
    Chief Executive Officer

 

    3  

 

 

 

1 Year Cardax (CE) Chart

1 Year Cardax (CE) Chart

1 Month Cardax (CE) Chart

1 Month Cardax (CE) Chart

Your Recent History

Delayed Upgrade Clock